Lilly Suffers Setback In Zyprexa Suit

Law360, New York (July 2, 2007, 12:00 AM EDT) -- The judge overseeing the multidistrict litigation involving controversial antipsychotic drug Zyprexa has shot down Eli Lilly's request for summary judgment, ruling that a set of plaintiffs has a right to pursue its fraud and overpricing claims against the pharmaceutical giant.

On Thursday, Senior U.S. District Judge Jack Weinstein sided against Lilly in a portion of the chaotic litigation, ruling that the group of direct purchasers should be allowed to proceed with their overpayment complaint.

“While the case is close, plaintiffs have sufficiently demonstrated for purposes of...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.